Showing results (171-180 of 777) with videos related to

Sort By:
Pageof 78
Cancer Cell|November 16, 2005
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from BortezomibDharminder Chauhan, Laurence Catley, Guilan Li, et al.
Oncotarget|November 9, 2017
HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancerTeru Hideshima, Ralph Mazitschek, Jun Qi, et al.
Oncotarget|August 26, 2021
Correction: HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancerTeru Hideshima, Ralph Mazitschek, Jun Qi, et al.
Cancer Research|September 6, 2005
Effects of PS-341 on the activity and composition of proteasomes in multiple myeloma cellsMikael Altun, Paul J Galardy, Reshma Shringarpure, et al.
Annual Review of Medicine|January 31, 2002
Thalidomide: emerging role in cancer medicinePaul Richardson, Teru Hideshima, Kenneth Anderson
British Journal of Haematology|April 10, 2008
p38 mitogen-activated protein kinase inhibitor LY2228820 enhances bortezomib-induced cytotoxicity and inhibits osteoclastogenesis in multiple myeloma; therapeutic implicationsKenji Ishitsuka, Teru Hideshima, Paola Neri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
Interactions of the Hdm2/p53 and proteasome pathways may enhance the antitumor activity of bortezomibMelissa G Ooi, Patrick J Hayden, Vassiliki Kotoula, et al.
Blood|March 5, 2008
Dual targeting of the proteasome regulates survival and homing in Waldenstrom macroglobulinemiaAldo M Roccaro, Xavier Leleu, Antonio Sacco, et al.
Plos One|December 3, 2015
Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma CellsRikio Suzuki, Shohei Kikuchi, Takeshi Harada, et al.
British Journal of Haematology|March 25, 2010
Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivoKihyun Kim, Sun-Young Kong, Mariateresa Fulciniti, et al.
Pageof 78